Portage Biotech Inc., 10% Owner at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 71,300 shares at $28.61 ($2.0M) on 2018-01-03, disclosed to the SEC on 2018-01-04.
Open-market sale of $2.0M BHVN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.61 | 35,650 | $1.0M | 50.0% |
| 2 | $28.61 | 35,650 | $1.0M | 50.0% |
| Total | $28.61 avg | 71,300 | $2.0M | 100% |
| Filing → |
| BHVN | SELL | 2018-01-09 | $5.1M | — | Filing → |